Emcure Pharma European arm Tillomed buys strategic pharma portfolio from Manx for 19.7 million pounds Ruchika Sharma4 April 2025 4:30 PM ISTPune: Tillomed Laboratories Limited, a subsidiary of Emcure Pharmaceuticals Ltd. and a European pharma company, has entered into an Asset...
AstraZeneca Imfinzi-based perioperative regimen approved in EU for resectable non-small cell lung cancer Ruchika Sharma4 April 2025 3:30 PM ISTCambridge: AstraZeneca has announced that the Company's Imfinzi (durvalumab) in combination with chemotherapy has been approved in the European Union...
USFDA grants nod for Amgen Uplizna as first treatment for rare immune disorder Ruchika Sharma4 April 2025 2:30 PM ISTThousand Oaks: Amgen has announced that the Company has received approval from the U.S. Food and Drug Administration (FDA) for...
Natco Pharma Executive VP - Technology Transfer, Intellectual Property Rights & Regulatory Affairs (API), Dr Ramesh Dandala, superannuates Ruchika Sharma4 April 2025 1:30 PM ISTTelangana: Natco Pharma has announced the superannuation of Dr Ramesh Dandala, Executive Vice President - Technology Transfer, Intellectual...
Shilpa Medicare marketing partner Amneal Pharma unveils multiple myeloma treatment Boruzu Ruchika Sharma4 April 2025 12:30 PM ISTKarnataka: Shilpa Medicare has announced that the Company's marketing partner, Amneal Pharmaceuticals, has launched BORUZU, (Bortezomib...
Novo Nordisk reshapes Executive management team Ruchika Sharma4 April 2025 11:30 AM IST Novo Nordisk HA has announced that Camilla Sylvest has decided to leave the company after a distinguished career of 28 years with the Company,...
Bayer AG arm Vividion Therapeutics doses first patient in Phase I study of Inhibitor for advanced solid tumors treatment Ruchika Sharma4 April 2025 10:30 AM ISTSan Diego: Vividion Therapeutics, Inc. has announced that the first patient has been dosed in a Phase I clinical trial evaluating VVD-159642, an...
Zydus Lifesciences gets CDSCO panel nod to conduct bioequivalence study of Eltrombopag for oral suspension Dr. Divya Colin3 April 2025 6:00 PM ISTNew Delhi: Zydus Lifesciences has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation...
Novartis receives USFDA accelerated approval for Vanrafia for proteinuria reduction in primary IgA nephropathy Ruchika Sharma3 April 2025 4:30 PM ISTEast Hanover: Novartis has received accelerated approval from the US Food and Drug Administration (FDA) for Vanrafia...
Martin A. Makary sworn in as FDA Commissioner Ruchika Sharma3 April 2025 3:33 PM ISTRenowned surgeon-scientist and health policy expert, Martin A. Makary, M.D., M.P.H., took the oath of office to become the 27th Commissioner of Food...
USFDA grants orphan drug designation to Sanofi Rilzabrutinib for two rare diseases Ruchika Sharma3 April 2025 2:45 PM ISTParis: Sanofi has announced that the US Food and Drug Administration (FDA) has granted orphan drug designation to Rilzabrutinib, an...
Lupin UK arm acquires Renascience Pharma for over Rs 138 crore Ruchika Sharma3 April 2025 1:30 PM ISTMumbai: Lupin Healthcare (UK) Limited, the wholly owned subsidiary of global pharma major Lupin Limited, has announced the acquisition of ...
